Mallinckrodt
Mallinckrodt gets court approval for second bankruptcy, reducing opioid settlement by $1B
Anika Sharma
Mallinckrodt’s commitment to pay a hefty $1.7 billion opioid settlement has taken a significant hit due to the company’s second ...
Mallinckrodt Launches New FDA-Approved ADHD Drug Lisdexamfetamine
Anika Sharma
Mallinckrodt, a global specialty pharmaceutical company, has made waves with an announcement that’s set to reshape the Attention-Deficit/Hyperactivity Disorder (ADHD) ...
Following $1.7B Opioid Settlement, Mallinckrodt Prepares for Second Round of Bankruptcy Proceedings
Anika Sharma
In a recent development, Mallinckrodt has formally announced its decision to initiate another round of bankruptcy proceedings, marking its second ...
